Drug    DrugBank | All Description Patterns💬 Info on mouse-over

9 / 17,542 descriptions

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY
On map, Yellow: Drug target genes
Disease ID
 1  Act-385781a (actelion epoprostenol)  Epoprostenol  [2] D00106, D01337 💬  [1] PTGIR 💬  [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction  [1] 86 💬 
 2  Current marketed flolan (epoprostenol sodium)  Epoprostenol  [2] D00106, D01337 💬  [1] PTGIR 💬  [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction  [1] 86 💬 
 3  Epoprostenol  Epoprostenol  [2] D00106, D01337 💬  [1] PTGIR 💬  [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction  [1] 86 💬 
 4  Epoprostenol for injection  Epoprostenol  [2] D00106, D01337 💬  [1] PTGIR 💬  [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction  [1] 86 💬 
 5  Epoprostenol sodico  Epoprostenol  [2] D00106, D01337 💬  [1] PTGIR 💬  [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction  [1] 86 💬 
 6  Epoprostenol sodium  Epoprostenol  [2] D00106, D01337 💬  [1] PTGIR 💬  [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction  [1] 86 💬 
 7  Epoprostenol-actelion  Epoprostenol  [2] D00106, D01337 💬  [1] PTGIR 💬  [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction  [1] 86 💬 
 8  Epoprostenolo per iniezione  [1] 86 💬 
 9  New thermo stable formulation of epoprostenol sodium  Epoprostenol  [2] D00106, D01337 💬  [1] PTGIR 💬  [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction  [1] 86 💬